Safety and Effectiveness of Integrative Korean Medicine Treatment for Traffic Accident During Pregnancy

NCT ID: NCT05658939

Last Updated: 2024-03-05

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 126 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-05-02
• Study Completion Date: 2022-08-18

Brief Summary

The purpose of this study is to reveal the efficacy and safety of integrative korean medicine treatment for pregnant women who suffered a traffic accident. A retrospective chart review and follow-up were conducted.

From January 1, 2018 to April 22, 2022, pregnant women who visited an korean medicine hospital due to a traffic accident were subjected to a retrospective study of patient medical records and follow-up.

Detailed Description

Medical records of selected patients will be analyzed, and telephone or internet surveys will be conducted for each patient. The survey questions are Numeric rating scale(NRS), Neck disability index(NDI) score, Oswestry Disability Index(ODI) score, Shoulder Pain and Disability Index(SPADI) score, The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) score, EuroQol 5-dimension 5-level(EQ-5D-5L) score and patient global impression of change (PGIC) score, etc.

Conditions

Traffic Accident

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: PROSPECTIVE

Interventions

Phone/Internet survey

A questionnaire about the current symptoms and satisfaction for received treatment will be conducted over the phone/internet for patients.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients who visited hospital due to symptoms caused by a traffic accident during pregnancy and received one or more korean medicine treatment as an inpatient or outpatient treatment
• Patients who understand the purpose and contents of the study and agree to participate in the study
• Patients with communication skills and mental/physical ability to respond appropriately to questionnaires

Exclusion Criteria

• Patients under the age of 18 at the time of the first visit
• Patients who received treatment without being aware of pregnancy
• Patients who have undergone only consultation or Western treatment at the hospital
• Patients whose participation in the study is difficult for the researcher to judge

• Minimum Eligible Age: 18 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Jaseng Medical Foundation

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sunah Kim

Role: PRINCIPAL_INVESTIGATOR

Daejeon Jaseng Hospital of Korean Medicine

Locations

Daejeon Jaseng Hospital of Korean Medicine

Daejeon, , South Korea

Countries

South Korea

Other Identifiers

JS-CT-2022-05

Identifier Type: -

Identifier Source: org_study_id